ArticleJournal of gynecologic oncology2024

Efficacy and safety of combined anlotinib-oral etoposide treatment for patients with platinum-resistant ovarian cancer.

Shuai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.